PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
27-Aug-2024 Tenon Medical Appoints Medical Device Veteran, Kevin Williamson, Chief Financial Officer AccessWire
27-Aug-2024 Albert Plastic Surgery's Revolutionary Closed Rhinoplasty Procedure AccessWire
27-Aug-2024 Ensysce Biosciences Announces IRB Approval for Key MPAR Study AccessWire
27-Aug-2024 Raise the Woof at VRCCO's Second Annual Benefit Gala AccessWire
27-Aug-2024 AI in Clinical Trials Market Expected to Reach USD 4.4 Billion by 2032 Global Market Insights, Inc.
27-Aug-2024 BioPhorum acquires training organization Brookwood Global BioPhorum
27-Aug-2024 ENA Respiratory Progresses Phase Ib Study of its Dry Powder Formulation of Intranasal Innate Immunomodulator INNA-051 ENA Respiratory
27-Aug-2024 Microbiotica’s Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies Microbiotica
27-Aug-2024 Leadership Appointments at RQM+ RQM+
27-Aug-2024 ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse ConTIPI Medical Ltd
27-Aug-2024 European Commission approves Celltrion’s SteQeyma® (CT-P43), a biosimilar to Stelara® (ustekinumab), for the treatment of multiple chronic inflammatory diseases Celltrion
27-Aug-2024 UCB to Accelerate Innovation and Strategic Partnerships, Divesting Mature Product Portfolio in China UCB
27-Aug-2024 Medigene AG implements announced 2:1 share capital reduction and consolidation of the shares effective August 29, 2024 Medigene AG
27-Aug-2024 RedHill’s Opaganib Granted Orphan Drug Designation by the FDA for Childhood Cancer, Neuroblastoma RedHill Biopharma
27-Aug-2024 Regeneron Receives EC Approval for Ordspono (odronextamab) to Treat R/R Follicular Lymphoma or R/R Diffuse Large B-cell Lymphoma Regeneron
27-Aug-2024 Microbiotica’s Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies Microbiotica
27-Aug-2024 ENA Respiratory Progresses Phase Ib Study of its Dry Powder Formulation of Intranasal Innate Immunomodulator INNA-051 ENA Respiratory
27-Aug-2024 Transgene — Preclinical Proof-of-Concept Data of Oncolytic Virus TG6050 Published in JITC Transgene
27-Aug-2024 New drug trial offers hope to 200,000 people with ‘hidden’ lung condition EMBARC
27-Aug-2024 Curatis auf Kurs: Einreichung des Antrags für Orphan-Drug-Designation des wichtigsten Produktkandidaten in den USA Curatis Holding AG